» Go to news main

Dr. Mark Filiaggi awarded Early Stage Commercialization Funding

Posted by Marilyn Klein on March 29, 2012 in Research, Awards

Dr. Mark Filiaggi, Department of Applied Oral Sciences, along with co-investigators Dr. Bob Abraham and PhD student Arash Momeni, has been awarded $49,500 of Early Stage Commercialization Funding from Innovacorp for "Commercialization of CaP Liquid Embolic System."

This funding will help develop and commercialize a liquid embolic material. This new material is designed to be injected into blood vessels where it will form a solid or gel-like embolus (blockage).

Embolization is commonly used to stop uncontrolled bleeding or to block blood flow to a target tissue, such as a tumour. The researchers believe this new material will have several advantages over existing liquid embolics and intend to initially focus its use on the treatment of tumours.